Behavioral-state modulation of inhibition is context-dependent and cell type specific in mouse visual cortex

Abstract

Cortical responses to sensory stimuli are modulated by behavioral state. In the primary visual cortex (V1), visual responses of pyramidal neurons increase during locomotion. This response gain was suggested to be mediated through inhibitory neurons, resulting in the disinhibition of pyramidal neurons. Using in vivo two-photon calcium imaging in layers 2/3 and 4 in mouse V1, we reveal that locomotion increases the activity of vasoactive intestinal peptide (VIP), somatostatin (SST) and parvalbumin (PV)-positive interneurons during visual stimulation, challenging the disinhibition model. In darkness, while most VIP and PV neurons remained locomotion responsive, SST and excitatory neurons were largely non-responsive. Context-dependent locomotion responses were found in each cell type, with the highest proportion among SST neurons. These findings establish that modulation of neuronal activity by locomotion is context-dependent and contest the generality of a disinhibitory circuit for gain control of sensory responses by behavioral state.

Article and author information

Author details

  1. Janelle MP Pakan

    Centre for Integrative Physiology, University of Edinburgh, Edinburgh, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9384-8067
  2. Scott C Lowe

    Institute for Adaptive and Neural Computation, University of Edinburgh, Edinburgh, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  3. Evelyn Dylda

    Centre for Integrative Physiology, University of Edinburgh, Edinburgh, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1883-4498
  4. Sander W Keemink

    Institute for Adaptive and Neural Computation, University of Edinburgh, Edinburgh, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  5. Stephen P Currie

    Centre for Integrative Physiology, University of Edinburgh, Edinburgh, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  6. Christopher A Coutts

    Centre for Integrative Physiology, University of Edinburgh, Edinburgh, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  7. Nathalie LI Rochefort

    Centre for Integrative Physiology, University of Edinburgh, Edinburgh, United Kingdom
    For correspondence
    n.rochefort@ed.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3498-6221

Funding

Wellcome (102857/Z/13/Z)

  • Nathalie LI Rochefort

EuroSpin Erasmus Mundus Program

  • Sander W Keemink

Royal Society (102857/Z/13/Z)

  • Nathalie LI Rochefort

European Commission (Marie Curie Actions (FP7), MC-CIG 631770)

  • Nathalie LI Rochefort

Patrick Wild Centre

  • Nathalie LI Rochefort

The Shirley Foundation

  • Nathalie LI Rochefort

RS MacDonald Charitable Trust (Seedcorn Grant 21)

  • Nathalie LI Rochefort

University Of Edinburgh (Graduate School of Life Sciences)

  • Evelyn Dylda

European Commission (Marie Curie Actions (FP7), IEF 624461)

  • Janelle MP Pakan

EPSRC Doctoral Training Centre in Neuroinformatics (EP/F500385/1 and BB/F529254/1)

  • Sander W Keemink

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Thomas D Mrsic-Flogel, University of Basel, Switzerland

Ethics

Animal experimentation: All procedures were approved by the University of Edinburgh animal welfare committee, and were performed under a UK Home Office Project License (PPL No. 60/4570).

Version history

  1. Received: February 3, 2016
  2. Accepted: August 22, 2016
  3. Accepted Manuscript published: August 23, 2016 (version 1)
  4. Accepted Manuscript updated: September 2, 2016 (version 2)
  5. Accepted Manuscript updated: September 9, 2016 (version 3)
  6. Version of Record published: September 20, 2016 (version 4)
  7. Version of Record updated: September 6, 2017 (version 5)

Copyright

© 2016, Pakan et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 8,468
    views
  • 1,772
    downloads
  • 151
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Janelle MP Pakan
  2. Scott C Lowe
  3. Evelyn Dylda
  4. Sander W Keemink
  5. Stephen P Currie
  6. Christopher A Coutts
  7. Nathalie LI Rochefort
(2016)
Behavioral-state modulation of inhibition is context-dependent and cell type specific in mouse visual cortex
eLife 5:e14985.
https://doi.org/10.7554/eLife.14985

Share this article

https://doi.org/10.7554/eLife.14985

Further reading

    1. Genetics and Genomics
    2. Neuroscience
    Bohan Zhu, Richard I Ainsworth ... Javier González-Maeso
    Research Article

    Genome-wide association studies have revealed >270 loci associated with schizophrenia risk, yet these genetic factors do not seem to be sufficient to fully explain the molecular determinants behind this psychiatric condition. Epigenetic marks such as post-translational histone modifications remain largely plastic during development and adulthood, allowing a dynamic impact of environmental factors, including antipsychotic medications, on access to genes and regulatory elements. However, few studies so far have profiled cell-specific genome-wide histone modifications in postmortem brain samples from schizophrenia subjects, or the effect of antipsychotic treatment on such epigenetic marks. Here, we conducted ChIP-seq analyses focusing on histone marks indicative of active enhancers (H3K27ac) and active promoters (H3K4me3), alongside RNA-seq, using frontal cortex samples from antipsychotic-free (AF) and antipsychotic-treated (AT) individuals with schizophrenia, as well as individually matched controls (n=58). Schizophrenia subjects exhibited thousands of neuronal and non-neuronal epigenetic differences at regions that included several susceptibility genetic loci, such as NRG1, DISC1, and DRD3. By analyzing the AF and AT cohorts separately, we identified schizophrenia-associated alterations in specific transcription factors, their regulatees, and epigenomic and transcriptomic features that were reversed by antipsychotic treatment; as well as those that represented a consequence of antipsychotic medication rather than a hallmark of schizophrenia in postmortem human brain samples. Notably, we also found that the effect of age on epigenomic landscapes was more pronounced in frontal cortex of AT-schizophrenics, as compared to AF-schizophrenics and controls. Together, these data provide important evidence of epigenetic alterations in the frontal cortex of individuals with schizophrenia, and remark for the first time on the impact of age and antipsychotic treatment on chromatin organization.